Analysis of the interaction network relationship between drugs using a graph neural network

Area of Science:

• Computational biology
• Artificial intelligence in medicine
• Graph-based machine learning

Background:

• Increasing complexity of biochemical systems and vast biomedical data necessitate advanced computational models.
• Traditional relational models struggle with multi-relational dependencies and sparse data.
• Need for scalable, interpretable models for decision support and knowledge discovery.

Purpose of the Study:

• To present a novel, biologically grounded graph-based learning framework to address limitations in current biomedical modeling.
• To enhance the accuracy, interpretability, and robustness of computational models for pharmaceutical and biomedical data.
• To drive knowledge discovery and support next-generation decision-support systems.

Main Methods:

• A two-tiered system: PHARMNet (multi-relational GNN with memory-augmented attention) and INTERACT-SCOPE (ontology-guided optimization).
• PHARMNet uses relation-specific convolutions and semantic embedding alignment for latent dependencies.
• INTERACT-SCOPE incorporates ontology constraints, uncertainty estimation, and adaptive regularization for stability.

Main Results:

• Achieved state-of-the-art (SOTA) predictive performance across various pharmacological interactions.
• Demonstrated enhanced model interpretability and robustness, particularly in low-data/high-noise scenarios.
• Outperformed existing methods on drug-drug interaction datasets with AUC of 0.873 and F1-score of 0.831.

Conclusions:

• The framework offers a powerful and interpretable solution for healthcare informatics and biomedical discovery.
• Synergistic integration of AI, graph learning, and domain knowledge advances computational intelligence.
• Contributes to innovative, knowledge-driven advances in software engineering, AI, and biomedical informatics.